Lactobacillus crispatus  CTV-05  (Lactin-V,  Osel) 
is  a  live  biotherapeutic  product  that  contains  a 
naturally occurring vaginal strain of L. crispatus. The placebo formulation con-
tained the same inactive ingredients as Lactin-V, 
without L. crispatus CTV-05..

Clinic follow-up visits were scheduled 4, 8, 12, 
and  24  weeks  after  enrollment. The 
data from the questionnaire are not reported here.). The size of each 
blue bar represents the interquartile range. CFU denotes colony-forming 
units..

There were no apparent associations between 
the detection of L. crispatus CTV-05 at week 12 or 
week  24  and  adherence  to  the  assigned  treat-. Overall,  adherence  to  the  assigned 
treatment  was  high.